[On further cases of leukemia with several erythrocyte populations differring in their ABO-relationship].
D000017:ABO Blood-Group System; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000937:Antigen-Antibody Reactions; D004912:Erythrocytes / Q000503:physiopathology*; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D007106:Immune Sera; D007951:Leukemia, Myeloid / Q000503:physiopathology*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000017:ABO Blood-Group System; D007106:Immune Sera; D000324:Adrenocorticotropic Hormone; D015122:Mercaptopurine; D011241:Prednisone
Uber weitere Erkrankungen an Leukämie mit mehreren in ihrer ABO-Zugehörigkeit voneinander abweichenden Erythrozytenpopulationen.